Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Perrigo Gains US Approval For OTC Guaifenesin/Pseudoephedrine Manufacturing

04 Feb 2022

• By Malcolm Spicer

• Source: Alamy

Related Content

Reckitt’s Revenues Soar On Strength Of Adams Brands, Product Innovations

16 Feb 2009

Perrigo Ships Guaifenesin/PSE Tablets<em>,</em> But Single-Ingredient Snags Linger

05 Jan 2016

Perrigo Glows From Mucinex Private Label Plan, Starboard Plug

15 Sep 2017

OTC Decisions In March: Lumify Single-Use, Aleve Arthritis-Grip Cap Labeling, And More Prilosec, Mucinex Copies

08 Apr 2020

OTC Decisions In April: Naproxen CV Risk Warning, Sun US Line Rises, Perrigo Omeprazole 'Melt In Mouth' Flag

07 May 2020

Perrigo ANDA Approval Brings New Options To Generic Mucinex DM Maximum Strength Portfolio

09 Mar 2018

Related Companies

Perrigo Company PLC

Reckitt Benckiser Group PLC

Aurobindo Pharma Limited

Sun Pharmaceutical Industries Ltd.

Allergan plc

Teva Pharmaceutical Industries Ltd.

Additional Topics

International Ireland Europe United States Approvals OTC Drugs Commercial Advertising, Marketing & Sales Business Strategies Companies Compliance Consumer FDA Drug Approval Standards Ingredients Manufacturing Regulation Prescription To OTC Switch

More from International

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.